Siemens Healthineers has approved a dividend of €0.95 per share for fiscal year 2024, with a payout ratio of 54% of net income. The company’s virtual annual shareholders' meeting saw broad support for all agenda items, reinforcing its strong financial performance despite economic challenges.
During the meeting, Supervisory Board Chair Ralf Thomas and Chief Executive Officer Bernd Montag highlighted the economic significance of the healthcare industry in Germany. Thomas emphasized that the sector employs approximately one million people and plays a vital role in global healthcare innovation.
Montag described the healthcare industry as a perfect fit for Germany, citing its foundation in knowledge, science, and trust. He urged the German government to prioritize healthcare within its economic, education, and innovation policies. "Germany remains a strong business location globally," he stated, calling for a shift toward optimism and action.
Siemens Healthineers has invested around €650 million in its German facilities, including Erlangen, Forchheim, Kemnath, and Rudolstadt. The company employs 73,000 people worldwide, working toward increasing access to healthcare, especially in underserved regions. Its goal is to raise the number of annual patient interactions from 2.6 billion to 3.3 billion by 2030, with 1.25 billion in low- and middle-income countries.
The shareholders’ meeting also addressed key business transformations, particularly in the Diagnostics segment and the ongoing integration of Varian, which has grown at a double-digit rate since its acquisition in 2021. Thomas praised the company’s ability to meet ambitious targets amid economic difficulties.
Additionally, shareholders approved the evolution of the remuneration system for the managing board, aligning it with global market requirements and incorporating stronger sustainability measures within variable compensation.
The publicly streamed event was followed by 756 viewers at its peak, with 114 questions addressed live by the company’s leadership. The overwhelming approval of the board's resolutions underscores continued confidence in Siemens Healthineers' strategy and long-term vision.
